[go: up one dir, main page]

NO20020812D0 - Anvendelse av bissulfonamider for fremstilling av legemidler for profylakse eller behandling av hyperlipidemi - Google Patents

Anvendelse av bissulfonamider for fremstilling av legemidler for profylakse eller behandling av hyperlipidemi

Info

Publication number
NO20020812D0
NO20020812D0 NO20020812A NO20020812A NO20020812D0 NO 20020812 D0 NO20020812 D0 NO 20020812D0 NO 20020812 A NO20020812 A NO 20020812A NO 20020812 A NO20020812 A NO 20020812A NO 20020812 D0 NO20020812 D0 NO 20020812D0
Authority
NO
Norway
Prior art keywords
hyperlipidemia
treatment
bisulfonamides
prophylaxis
drugs
Prior art date
Application number
NO20020812A
Other languages
English (en)
Other versions
NO20020812L (no
Inventor
Reinhard Kirsch
Hans-Ludwig Schaefer
Eugen Falk
Norbert Krass
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20020812D0 publication Critical patent/NO20020812D0/no
Publication of NO20020812L publication Critical patent/NO20020812L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20020812A 1999-09-01 2002-02-19 Anvendelse av bissulfonamider for fremstilling av legemidler for profylakse eller behandling av hyperlipidemi NO20020812L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19941559A DE19941559A1 (de) 1999-09-01 1999-09-01 Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie
PCT/EP2000/008026 WO2001016096A2 (de) 1999-09-01 2000-08-17 Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie

Publications (2)

Publication Number Publication Date
NO20020812D0 true NO20020812D0 (no) 2002-02-19
NO20020812L NO20020812L (no) 2002-04-30

Family

ID=7920369

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020812A NO20020812L (no) 1999-09-01 2002-02-19 Anvendelse av bissulfonamider for fremstilling av legemidler for profylakse eller behandling av hyperlipidemi

Country Status (23)

Country Link
US (1) US6632838B1 (no)
EP (1) EP1237859B1 (no)
JP (1) JP4982021B2 (no)
KR (1) KR20020023429A (no)
CN (1) CN1384742A (no)
AT (1) ATE380789T1 (no)
AU (1) AU775336B2 (no)
BR (1) BR0013723A (no)
CA (1) CA2383783A1 (no)
CZ (1) CZ2002708A3 (no)
DE (2) DE19941559A1 (no)
EE (1) EE200200088A (no)
HR (1) HRP20020178A2 (no)
HU (1) HUP0204282A2 (no)
IL (1) IL148147A0 (no)
MX (1) MXPA02001740A (no)
NO (1) NO20020812L (no)
NZ (1) NZ517485A (no)
PL (1) PL353205A1 (no)
RU (1) RU2002107996A (no)
SK (1) SK2722002A3 (no)
WO (1) WO2001016096A2 (no)
ZA (1) ZA200201592B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366619A1 (en) * 2001-05-11 2005-02-07 Biovitrum Ab Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
US7718650B2 (en) * 2001-05-11 2010-05-18 Biovitrum Ab Aryl sulfonamide compounds for treating obesity
KR100922486B1 (ko) * 2001-05-11 2009-10-20 바이오비트럼 에이비(피유비엘) 비만, 제 ⅱ 형 당뇨병 및 ｃｎｓ 장애의 치료를 위한신규한 아릴술폰아미드 화합물
US20070185248A1 (en) * 2004-06-25 2007-08-09 Polyone Corporation Intumescent polylefin nanocomposites and their use
JP4925629B2 (ja) * 2005-09-02 2012-05-09 住友化学株式会社 スルホンアミド化合物
WO2008129288A2 (en) * 2007-04-19 2008-10-30 Boehringer Ingelheim International Gmbh Disulfonamides useful in the treatment of inflammation
TW200930368A (en) * 2007-11-15 2009-07-16 Astrazeneca Ab Bis-(sulfonylamino) derivatives in therapy
TW200930369A (en) * 2007-11-15 2009-07-16 Astrazeneca Ab Bis-(sulfonylamino) derivatives in therapy
US20090163586A1 (en) * 2007-12-20 2009-06-25 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy 205
US20100292279A1 (en) * 2009-05-14 2010-11-18 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353357A (en) * 1970-09-14 1974-05-15 Pfizer Substituted 5-sulphamylbenzoic acids
NL7310889A (no) * 1972-08-12 1974-02-14
DE2459394A1 (de) * 1974-12-16 1976-06-24 Hoechst Ag Basisch substituierte benzol-1,3- disulfonamide und verfahren zu ihrer herstellung
FR2517202B1 (fr) * 1981-12-02 1986-07-04 Choay Sa Compositions pharmaceutiques presentant des proprietes normolipemiantes et contenant des composes ayant une structure du type benzenesulfonamides n-substitues
DE3713757A1 (de) 1987-04-24 1988-11-10 Hoechst Ag Benzolsulfonamidderivate und verfahren zu ihrer herstellung
DE3905075A1 (de) * 1989-02-18 1990-08-30 Hoechst Ag Benzolsulfonamide und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JP2003508381A (ja) 2003-03-04
NO20020812L (no) 2002-04-30
KR20020023429A (ko) 2002-03-28
HRP20020178A2 (en) 2004-02-29
EE200200088A (et) 2003-04-15
ZA200201592B (en) 2003-01-29
DE19941559A1 (de) 2001-03-15
AU7409900A (en) 2001-03-26
SK2722002A3 (en) 2002-07-02
RU2002107996A (ru) 2003-11-20
CZ2002708A3 (cs) 2002-05-15
IL148147A0 (en) 2002-09-12
HUP0204282A2 (hu) 2003-06-28
WO2001016096A3 (de) 2002-07-04
BR0013723A (pt) 2002-05-07
NZ517485A (en) 2004-01-30
US6632838B1 (en) 2003-10-14
AU775336B2 (en) 2004-07-29
CN1384742A (zh) 2002-12-11
ATE380789T1 (de) 2007-12-15
DE50014850D1 (de) 2008-01-24
CA2383783A1 (en) 2001-03-08
MXPA02001740A (es) 2002-08-06
PL353205A1 (en) 2003-11-03
WO2001016096A2 (de) 2001-03-08
EP1237859B1 (de) 2007-12-12
EP1237859A2 (de) 2002-09-11
JP4982021B2 (ja) 2012-07-25

Similar Documents

Publication Publication Date Title
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BR0312729A (pt) Novos derivados de indol-3-enxofre
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
DE60305514D1 (de) Neue verwendung von benzothiazolderivaten
SE0202462D0 (sv) Novel use
ATE195315T1 (de) Indolocarbazol-imide und deren verwendung
NO20024005D0 (no) Pteridinforbindelser for behandling av psoriasis
DE50310516D1 (de) Fredericamycin-derivate
ATE294185T1 (de) Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediäre zur herstellung der derivate
NO20062905L (no) Nye hydroksaminsyreestere og farmasoytisk anvendelse derav
HUP9802629A2 (hu) 1,3-Bisz(1,2,4-triazolil)-2-propanol-származékok felhasználása rákos megbetegedések kezelésére szolgáló gyógyszerkészítmények előállítására
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
NO20050073L (no) Ringsubstituerte difenylazetidinoner, deres fremstilling, deres anvendelse samt legemidler inneholdende forbindelsene
EE200000527A (et) Faktorit Xa pärssivad heterotsüklilised derivaadid
NO20020812D0 (no) Anvendelse av bissulfonamider for fremstilling av legemidler for profylakse eller behandling av hyperlipidemi
DE69210091D1 (de) Leukotrien-B4-Antagonisten
BR0200341A (pt) Bifenilsulfonamidas proveitosas como inibidores de metaloproteases da matriz
ATE287874T1 (de) Heterozyklische verbindungen mit faktor xa hemmender wirkung
ATE231849T1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
HUP9901376A2 (hu) 1-Metil-karbapenem-származékok, alkalmazásuk, előállításuk, ezeket tartalmazó gyógyszerkészítmények
DE50006603D1 (de) Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
PT1156805E (pt) Utilizacao de sistenas piliciclicos de tiazole para a fabricacao de medicamentospara a profilaxia ou o tratamento de obesidade
YU5899A (sh) Derivati pirolidina i piperidina, postupak za njihovu proizvodnju, njihova primena za proizvodnju lekova i lekovi koji ih sadrže
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application